PsychoGenics Inc. Expands its In Vivo Capabilities with the Addition of Preclinical Magnetic Resonance Imaging Technology Services in Partnership with Ekam Imaging

TARRYTOWN, N.Y. & BOSTON--(BUSINESS WIRE)--PsychoGenics Inc. and Ekam Imaging, Inc., today announced the establishment of an alliance to provide Ekam’s specialized imaging services in awake animals to complement PsychoGenics’ testing capabilities and drug discovery services.